A Case of Appendiceal Adenocarcinoma with Clinical Benefit from FOLFOX and Bevacizumab
A 44-year-old woman presented with lower abdominal pain and bilateral ovarian masses on ultrasound. Exploratory laparotomy revealed extensive peritoneal and intra-abdominal disease and an abnormal appendix. Bilateral salpingo-oophorectomy, infracolic omentectomy, ileocolic resection and primary anas...
Main Authors: | Erin D. Powell, D.Blair Macdonald, Akram M. Elkeilani, Timothy R. Asmis |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2009-07-01
|
Series: | Case Reports in Oncology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/229245 |
Similar Items
-
Sustained Stable Disease with Capecitabine plus Bevacizumab in Metastatic Appendiceal Adenocarcinoma: A Case Report
by: David Arias Ron, et al.
Published: (2020-02-01) -
Successful Treatment of Metastatic Anal Canal Adenocarcinoma with mFOLFOX6 + Bevacizumab
by: Mototsugu Matsunaga, et al.
Published: (2016-04-01) -
Retrospective analysis on the clinical efficacy of bevacizumab combined with FOLFOX4 in the first line treatment of metastatic colorectal cancer
by: Eun Mi Lee, et al.
Published: (2017-12-01) -
Single-cell analysis reveals cellular reprogramming in advanced colon cancer following FOLFOX-bevacizumab treatment
by: Meiling Yang, et al.
Published: (2023-07-01) -
Appendiceal adenocarcinoma—Two unique cases of adenocarcinoma ex‐goblet cell carcinoid
by: Mairead M. Hennessy, et al.
Published: (2019-04-01)